WELL Health and HEALWELL AI Launch WELLTRUST for AI-Driven Clinical Trial Recruitment

Event summary

  • WELL Health and HEALWELL AI launched WELLTRUST, a platform for secure, consent-driven patient identification for clinical research within WELL-operated clinics in Canada.
  • WELLTRUST leverages HEALWELL’s DARWEN™ AI platform to accelerate clinical trial recruitment by identifying high-fit patients with chronic or complex conditions.
  • The platform includes a unified privacy, consent, and data-governance layer to meet Canadian privacy and regulatory standards.
  • WELL Health operates over 240 clinics in Canada and supports more than 43,000 healthcare providers across the US and Canada.

The big picture

The launch of WELLTRUST represents a strategic move to integrate AI-driven solutions into clinical research, addressing the long-standing challenge of patient recruitment. By combining WELL Health’s extensive clinical footprint with HEALWELL AI’s advanced AI capabilities, the platform aims to accelerate research and improve patient access to innovative therapies. This initiative aligns with broader industry trends towards leveraging technology to enhance efficiency and outcomes in healthcare.

What we're watching

Adoption Pace
How quickly WELLTRUST will be adopted by patients and research partners, and whether it can significantly reduce clinical trial recruitment times.
Regulatory Compliance
Whether WELLTRUST can maintain compliance with evolving privacy and regulatory standards as it expands its use cases.
Market Differentiation
The extent to which WELLTRUST can differentiate itself from other AI-driven clinical trial recruitment platforms in the market.